Home / Tobramycin / Austria
AT ATC S01AA12 · updated 2 Nov 2026
Tobramycin shortage in Austria
Is there a Tobramycin shortage in Austria?
Yes. As of 2 Nov 2026, 1 Tobramycin product is reported short in Austria, the first since 3 Sep 2026. The company estimate for the return is 7 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Spain, Czechia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Tobrex Augensalbe, 3,5 g limited | Novartis Pharma GmbH | 3 Sep 2026 | 7 Dec 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).